Cytokinetics Inc (CYTK)
47.67
-2.19
(-4.39%)
USD |
NASDAQ |
Nov 21, 16:00
47.86
+0.19
(+0.40%)
After-Hours: 20:00
Cytokinetics Price to Book Value
Price to Book Value Chart
Historical Price to Book Value Data
Date | Value |
---|---|
September 27, 2024 | 56.73 |
September 26, 2024 | 57.05 |
September 25, 2024 | 57.10 |
September 24, 2024 | 57.08 |
September 23, 2024 | 56.46 |
September 20, 2024 | 58.28 |
September 19, 2024 | 60.27 |
September 18, 2024 | 60.63 |
September 17, 2024 | 60.87 |
September 16, 2024 | 61.51 |
September 13, 2024 | 60.57 |
September 12, 2024 | 58.60 |
September 11, 2024 | 58.28 |
September 10, 2024 | 58.69 |
September 09, 2024 | 60.52 |
September 06, 2024 | 58.63 |
September 05, 2024 | 60.62 |
September 04, 2024 | 59.50 |
September 03, 2024 | 59.14 |
August 30, 2024 | 61.87 |
August 29, 2024 | 62.21 |
August 28, 2024 | 60.19 |
August 27, 2024 | 60.54 |
August 26, 2024 | 61.86 |
August 23, 2024 | 62.13 |
Date | Value |
---|---|
August 22, 2024 | 60.97 |
August 21, 2024 | 61.33 |
August 20, 2024 | 61.62 |
August 19, 2024 | 61.20 |
August 16, 2024 | 61.24 |
August 15, 2024 | 61.85 |
August 14, 2024 | 60.57 |
August 13, 2024 | 60.78 |
August 12, 2024 | 60.89 |
August 09, 2024 | 60.47 |
August 08, 2024 | 58.53 |
August 07, 2024 | 55.52 |
August 06, 2024 | 57.97 |
August 05, 2024 | 57.85 |
August 02, 2024 | 61.86 |
August 01, 2024 | 62.70 |
July 31, 2024 | 63.89 |
July 30, 2024 | 65.13 |
July 29, 2024 | 63.98 |
July 26, 2024 | 64.63 |
July 25, 2024 | 63.34 |
July 24, 2024 | 61.50 |
July 23, 2024 | 62.12 |
July 22, 2024 | 62.17 |
July 19, 2024 | 61.07 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
7.201
Minimum
Oct 09 2020
176.81
Maximum
Sep 27 2021
38.66
Average
24.98
Median
Apr 26 2022
Price to Book Value Benchmarks
Ocugen Inc | 6.459 |
Scholar Rock Holding Corp | 31.55 |
Mirum Pharmaceuticals Inc | 8.996 |
NeuroBo Pharmaceuticals Inc | 1.563 |
Edgewise Therapeutics Inc | 6.200 |
Price to Book Value Related Metrics
PS Ratio | 1584.03 |
Price | 47.67 |
Earnings Yield | -11.29% |
Market Cap | 5.626B |